Navigation Links
Consultancy agreement with Scorpion Performance Inc.
Date:3/6/2013

RENO, Nev., March 6, 2013 /PRNewswire/ -- Global Equity International Inc. (OTCQB Ticker: GEQU), a specialist consultancy firm based in Dubai and London has signed new consultancy contract with Scorpion Performance Inc., a Florida based corporation, bringing in a new long term client to the Company.  The contract states that Global Equity Partners Plc., a fully owned subsidiary and the operational arm of GEQU, will consult with Scorpion Performance Inc. to assist the company with a full IPO on the Dubai NASDAQ. Our agreed fees will be cash and equity based.

Scorpion Performance Inc. is a precision manufacturer with two distinct divisions.

  • Scorpion Racing Products is the marketing and distribution company for the automotive products that Scorpion Performance manufactures. Scorpion Racing Products' online ecommerce web site allows customers to buy direct.
  • Scorpion Medical, Inc. manufactures precision medical instruments and implants for the medical device industry. The company uses its latest technology equipment to produce the highest quality products with substantial speed and cost efficiency.

We at Global Equity International Inc. (GEQU) see Scorpion Performance Inc. being one of the market leaders in the U.A.E. for their medical products in particular and view the equity in Scorpion to be a tremendous long term asset for our Company and our shareholders. Peter Smith , CEO of Global Equity International Inc., commented: 'We have been talking to Scorpion Performance for many months now and we are delighted to be able to finally put pen to paper, Scorpion have a strong, innovative product range, great management and high ambition. We believe Scorpion will grow to become a market leader in its field in particular with its FDA approved medical technology."

SAFE HARBOR

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.

CONTACT:

Enzo Taddei – CFO & Director
Tel + 321 200 0142
Email: enzo@gepartnersplc.com


'/>"/>
SOURCE Global Equity International Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies
2. DMH International Announces Agreement with MyDICOM and ChangZhou Wealth Information & Technology Co. Ltd
3. Breg Signs Agreement with HealthTrust
4. DMH International Completes Agreement With Wake Forest University
5. Ventana and Biocare Medical sign p63 license agreement to aid in the differential diagnosis of benign and malignant prostate lesions
6. Medical Sales College Signs Training Agreement With TASSMA, Inc.
7. Simbionix Signs an Agreement with the Laparoscopic Surgical Skills Foundation (LSS)
8. Swiss Companies Debiotech and Valtronic Announce Partnership Agreement on the JewelPUMP for Diabetic Patients
9. Selexis Announces Expansion of R&D License Agreement with Amgen
10. ProGaming Platforms Corp. Executes Share Swap Agreement With BioMedix Ltd.
11. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... ... the North East region. Côté has 20+ years of experience within the beauty ... Côté worked with an array of high-end cosmetic brands, retail brands and outlets ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly popular SearchLight ... online modeling resource for fluorescence microscopists and optical system designers, enabling The Right ... years spanning the globe, SearchLight has become a tremendously popular tool for the ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... deodorant. On the heels of Thinksport’s award-winning sunscreen they’ve used the same scientific ... actually works! , Countless deodorants flood the aisles that contain harmful chemicals that ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product ... oil many times purer and more potent than the market has seen before. Swissx ... Switzerland, as well as a patented chromatography process for extraction, to produce its CBD ...
(Date:4/26/2017)... ... April 26, 2017 , ... Journal of Oral Implantology ... have severe consequences to overall dental health, including complications with speech, eating, and overcompensation ... dental implants to replace lost teeth. As the number of tooth replacements increase, it ...
Breaking Medicine News(10 mins):